Arterial hypertension in Ryazan region: data of the third section of the EPOHA study

Aim. To study the nine-year dynamics of prevalence, risk factors, approaches to the treatment of arterial hypertension (AH) in the Ryazan region according to a representative sample survey, to assess the impact of risk factors and cardiovascular diseases on achieving blood pressure (BP) control.Mate...

Full description

Saved in:
Bibliographic Details
Main Authors: E. A. Smirnova, Yu. V. Terekhovskaya, A. A. Molodtsova, S. S. Yakushin
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2019-07-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/3358
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850031027029803008
author E. A. Smirnova
Yu. V. Terekhovskaya
A. A. Molodtsova
S. S. Yakushin
author_facet E. A. Smirnova
Yu. V. Terekhovskaya
A. A. Molodtsova
S. S. Yakushin
author_sort E. A. Smirnova
collection DOAJ
description Aim. To study the nine-year dynamics of prevalence, risk factors, approaches to the treatment of arterial hypertension (AH) in the Ryazan region according to a representative sample survey, to assess the impact of risk factors and cardiovascular diseases on achieving blood pressure (BP) control.Material and methods. A representative sample of the population of the Ryazan region, created in 2002 by the method of step-by-step randomization, was reexamined in 2007 and 2016. The group of AH included people with blood pressure >140/90 mm Hg. with double measurement or normal blood pressure, receiving antihypertensive therapy. The role of risk factors (age, smoking, alcohol abuse, salt, obesity, burdened heredity, low physical activity) and cardiovascular diseases was analyzed.Results. In 2016, the prevalence of AH was 43,9%, the number of people receiving antihypertensive drugs — 89,5%, those who are treated effectively — 373%, which is higher than in 2007 (39,3%, 799% and 16,6%, respectively). Smoking (RR 1,23; 1,11-1,37, p=0,005), salt abuse (RR 1,11; 1,01-1,23, p=0,04) and obesity (RR 1,16; 1,06¬1,27 p=0,003) negatively effect on the effectiveness of AH treatment. Treatment of AH is more effective in the absence of cardiovascular diseases (35,0% vs. 26,8%), signs of chronic heart failure (24,9% vs. 34,9%) and intermittent claudication (8,3% vs. 31,7%), p <0,001.Conclusion. Over nine years, the standardized by age prevalence of AH has increased significantly, the number of individuals taking antihypertensive drugs and the treatment effectively, the structure of the drugs taken has changed positively. Smoking, obesity, salt abuse and the presence of diseases of the cardiovascular system adversely affect the effectiveness of therapy. Study participants: Yepikhina E. A., Biryukova Zh. A., Larina T. A., Ivushkina L. I., Kozakova Yu. V., Motsnaya O. A., Surova A. I., Skorobogatova S. Yu., Tolmacheva E. A., Golubeva I. V., Smagina E. V., Kiseleva E. A., Bulavchenkova O. N., Shvykova T. A., Bashmakova G. N., Soloveva N. N., Davydkina S.A., Gorbunova L. A., Khoteenkova N. V., Dukova E. V., Varlamova L. A., Vorobyova G. A., Korzhevskaya A. A., Tabolkina A. A., Nechaeva G. P., Vybornova E. Z., Kashapova L. M., Tarasova A. I., Ryazantseva L. L., Yakovleva N. S., Semenets A. A., Chikova N. A., Muravyova G.V., Chizhikova M. I.
format Article
id doaj-art-e3c099bba35d48b99565132f995f6c57
institution DOAJ
issn 1560-4071
2618-7620
language Russian
publishDate 2019-07-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-e3c099bba35d48b99565132f995f6c572025-08-20T02:59:05Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202019-07-0106495310.15829/1560-4071-2019-6-49-532687Arterial hypertension in Ryazan region: data of the third section of the EPOHA studyE. A. Smirnova0Yu. V. Terekhovskaya1A. A. Molodtsova2S. S. Yakushin3I. P. Pavlov Ryazan State Medical University; Regional Clinical Cardiology DispensaryI. P. Pavlov Ryazan State Medical UniversityRegional Clinical Cardiology DispensaryI. P. Pavlov Ryazan State Medical UniversityAim. To study the nine-year dynamics of prevalence, risk factors, approaches to the treatment of arterial hypertension (AH) in the Ryazan region according to a representative sample survey, to assess the impact of risk factors and cardiovascular diseases on achieving blood pressure (BP) control.Material and methods. A representative sample of the population of the Ryazan region, created in 2002 by the method of step-by-step randomization, was reexamined in 2007 and 2016. The group of AH included people with blood pressure >140/90 mm Hg. with double measurement or normal blood pressure, receiving antihypertensive therapy. The role of risk factors (age, smoking, alcohol abuse, salt, obesity, burdened heredity, low physical activity) and cardiovascular diseases was analyzed.Results. In 2016, the prevalence of AH was 43,9%, the number of people receiving antihypertensive drugs — 89,5%, those who are treated effectively — 373%, which is higher than in 2007 (39,3%, 799% and 16,6%, respectively). Smoking (RR 1,23; 1,11-1,37, p=0,005), salt abuse (RR 1,11; 1,01-1,23, p=0,04) and obesity (RR 1,16; 1,06¬1,27 p=0,003) negatively effect on the effectiveness of AH treatment. Treatment of AH is more effective in the absence of cardiovascular diseases (35,0% vs. 26,8%), signs of chronic heart failure (24,9% vs. 34,9%) and intermittent claudication (8,3% vs. 31,7%), p <0,001.Conclusion. Over nine years, the standardized by age prevalence of AH has increased significantly, the number of individuals taking antihypertensive drugs and the treatment effectively, the structure of the drugs taken has changed positively. Smoking, obesity, salt abuse and the presence of diseases of the cardiovascular system adversely affect the effectiveness of therapy. Study participants: Yepikhina E. A., Biryukova Zh. A., Larina T. A., Ivushkina L. I., Kozakova Yu. V., Motsnaya O. A., Surova A. I., Skorobogatova S. Yu., Tolmacheva E. A., Golubeva I. V., Smagina E. V., Kiseleva E. A., Bulavchenkova O. N., Shvykova T. A., Bashmakova G. N., Soloveva N. N., Davydkina S.A., Gorbunova L. A., Khoteenkova N. V., Dukova E. V., Varlamova L. A., Vorobyova G. A., Korzhevskaya A. A., Tabolkina A. A., Nechaeva G. P., Vybornova E. Z., Kashapova L. M., Tarasova A. I., Ryazantseva L. L., Yakovleva N. S., Semenets A. A., Chikova N. A., Muravyova G.V., Chizhikova M. I.https://russjcardiol.elpub.ru/jour/article/view/3358arterial hypertensionprevalence dynamicstreatment effectivenessrisk factors of cardiovascular diseases
spellingShingle E. A. Smirnova
Yu. V. Terekhovskaya
A. A. Molodtsova
S. S. Yakushin
Arterial hypertension in Ryazan region: data of the third section of the EPOHA study
Российский кардиологический журнал
arterial hypertension
prevalence dynamics
treatment effectiveness
risk factors of cardiovascular diseases
title Arterial hypertension in Ryazan region: data of the third section of the EPOHA study
title_full Arterial hypertension in Ryazan region: data of the third section of the EPOHA study
title_fullStr Arterial hypertension in Ryazan region: data of the third section of the EPOHA study
title_full_unstemmed Arterial hypertension in Ryazan region: data of the third section of the EPOHA study
title_short Arterial hypertension in Ryazan region: data of the third section of the EPOHA study
title_sort arterial hypertension in ryazan region data of the third section of the epoha study
topic arterial hypertension
prevalence dynamics
treatment effectiveness
risk factors of cardiovascular diseases
url https://russjcardiol.elpub.ru/jour/article/view/3358
work_keys_str_mv AT easmirnova arterialhypertensioninryazanregiondataofthethirdsectionoftheepohastudy
AT yuvterekhovskaya arterialhypertensioninryazanregiondataofthethirdsectionoftheepohastudy
AT aamolodtsova arterialhypertensioninryazanregiondataofthethirdsectionoftheepohastudy
AT ssyakushin arterialhypertensioninryazanregiondataofthethirdsectionoftheepohastudy